학력

• 2020.08

  연세대학교 의학과 박사

• 2014.02

  연세대학교 의학과 석사

• 2009.02

  연세대학교 의학과 학사

주요경력

• 2021.03 ~ 현재

  인하대병원 내분비내과 조교수

• 2020.03 ~ 2021.02

  인하대병원 내분비내과 임상조교수

• 2019.07 ~ 2020.02

  인하대병원 내분비내과 임상강사

• 2018.03 ~ 2019.06

  연세대학교 신촌세브란스병원 내분비내과 임상연구조교수

• 2017.05 ~ 2018.02

  연세대학교 신촌세브란스병원 내분비내과 전임의

• 2010.03 ~ 2014.02

  연세대학교 신촌세브란스병원 내과 전공의

• 2009.03 ~ 2010.02

  연세대학교병원 인턴

학회활동

• -

  대한당뇨병학회 윤리위원회 위원 (22-)

• -

  대한당뇨병학회 언론-홍보위원회 위원 (2020-21)

• -

  대한비만학회 언론-홍보위원회 위원 (2020-21)

• -

  대한당뇨병학회 평생회원

• -

  대한내분비학회 평생회원

• -

  대한내과학회 정회원

수상경력

• 2018.10

  연수구연상, International Conference on Diabetes and Metabolism (ICDM)

• 2018.05

  연수구연상, 대한당뇨병학회 춘계학술대회

주요 논문 및 저서

• 2022

  Cho Y, Rhee H, Kim Y, Lee M, Lee B-W, Kang ES, Cha B-S, Choi J-Y, Lee Y-H. Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study). BMC medicine 2022

• 2022

  Cho Y, Lee Y-H. State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis. Endocrinology and Metabolism. 2022

• 2021

  Cho Y, Jeong Y, Seo DH, Ahn SH, Hong S, Suh YJ, et al. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study. Atherosclerosis 2021

• 2020

  Han E, Cho Y (co-first), Kim K-W, Lee Y-H, Kang E-S, Cha B-S, Lee B-W. Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes. Medicine, 2020

• 2020

  Lee H-H, Cho Y (co-first), Choi YJ, Huh BW, Lee B-W, Kang ES, Park SW, Cha B-S, Lee EJ, Lee Y-H, Huh KB. Non‑alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study. Cardiovascular Diabetology (2020) 19:81

• 2020

  Cho Y, Ryeong-Hyeon Kim, Hyunki Park, Hye Jin Wang, Hyangkyu Lee, and Kang ES. Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue. Biomedicines 2020, 8, 512

• 2020

  Cho Y. Early development of bidirectional associations between sleep disturbance and diabetes. Diabetes & Metabolism Journal 2020;44:668-670

• 2019

  Cho Y(first), Kim MS, Nam CM, Kang ES. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Scientific Reports 2019; Vol.9(1) : 467

• 2019

  Cho Y(first), Lee Y, Kang ES, Cha B-S, Lee B-W. Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria. Journal of Diabetes and Its Complications 33 (2019) 585–591

• 2019

  Daham Kim, Yongin Cho (co-first), Cheol Ryong Ku, Hyein Jung, Ju Hyung Moon, Eui Hyun Kim, Dong Yeob Shin, Sun Ho Kim, Eun Jig Lee. Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease. Journal of Clinical Medicine (2019) [online published: 31 July 2019]

• 2019

  Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang. Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase-4 Inhibitors. Diabetes Care (2019) [published online August 20, 2019]

• 2019

  Cho Y, Lee H, Park HK, Choe EY, Wang HJ, Kim R-H, Kim Y, Kang ES. Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo. Journal of Atherosclerosis and Thrombosis (2019) [published online September 13, 2019]

• 2019

  Cho Y, Namki Hong 3,y, Kyung-won Kim 3, Sung joon Cho 3, Minyoung Lee 3, Yeon-hee LeeLee Y, Kang ES, Cha B-S, Lee B-W. The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine (2019) [online published: 9 October 2019]

• 2018

  Kim JJ, Jeong B, Cho Y, Kwon M-H, Lee Y-H, et al. The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus. Scientific Reports. 2018; Vol.8(1) : 6309

• 2018

  Lee JY, Cho Y, Lee M, Lee Y-H, Lee B-W et al. Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes. Diabetes & metabolism. 2018, Vol.44(5) : 452-455

• 2018

  Cho Y(first), Kang ES. Cardiovascular outcome trials of sodium glucose cotransporter 2 inhibitor and its possible cardioprotective mechanism. J Lipid Atheroscler 2018;7:21-31

• 2018

  Jang J-E, Cho Y (co-corresponding), Lee B-W, Shin E-S, Lee SH et al. Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis. Diabetes & metabolism journal. 2018; 42: e45.

• 2017

  Seo D, Cho Y(co-first), Lee S, Park S, Kim S, Park B, et al. Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients. The Korean journal of internal medicine 2017

• 2015

  Cho Y(co-first), Choe E, Lee Y-h, Seo JW, Choi Y, Yun Y, et al. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors. Metabolism. 2015;64(4):482-8.

• 2014

  Cho Y(co-first), Lee MJ, Choe EY, Jung CH, Joo DJ, Kim MS, et al. Statin therapy is associated with the development of new‐onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels. Liver Transplantation. 2014;20(5):557-63.

• 2014

  Choe EY, Wang HJ, Kwon O, Cho Y, Huh KH, Kim MS, et al. HMG CoA reductase inhibitor treatment induces dysglycemia in renal allograft recipients. Transplantation. 2014;97(4):419-25.

• 2014

  Choe EY, Cho Y(co-first), Choi Y, Yun Y, Wang HJ, Kwon O, et al. The effect of DPP-4 inhibitors on metabolic parameters in patients with type 2 diabetes. Diabetes & metabolism journal. 2014;38(3):211-9.

• 2014

  Shin DY, Kim KJ, Cho Y, Park KH, Hwang S, Chung WY, et al. Body mass index is associated with hypercholesterolemia following thyroid hormone withdrawal in thyroidectomized patients. International journal of endocrinology. 2014

• 2013

  Lee YK, Song SO, Kim KJ, Cho Y, Choi Y, Yun Y, et al. Glycemic effectiveness of metformin-based dual-combination therapies with sulphonylurea, pioglitazone, or dpp4-inhibitor in drug-naive Korean type 2 diabetic patients. Diabetes & metabolism journal. 2013;37(6):465-74.